Citigroup’s Picard Medical PMI Stock Holding History

Citigroup’s Portfolio PMI Stock Details PMI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$7.18K	Buy	+1,709	New	+$9.5K	﹤0.01%	5279
2026 Q2	–	Sell	-5	Closed	-$263	–	6419
2026 Q1	$263	Hold	5	–	–	﹤0.01%	5564
2025 Q4	$448	Buy	+5	New	+$1.18K	﹤0.01%	5600

Other funds holding PMI

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

EverSource Wealth Advisors Birmingham, Alabama $3.11B AUM 21.48% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Citigroup's PMI Position: Q3 2026 in Review

Citigroup opened a new position in Picard Medical (PMI) in Q3 2026: 1,709 shares worth $7.18K. The stake represents ﹤0.01% of the portfolio and ranks #5279 among its holdings. This is a return to the name: Citigroup previously reported a position in PMI as recently as Q1 2026.

Citigroup first reported a position in PMI in Q4 2025 and has held it in 3 quarters since. 9 funds tracked by Wall St. Rank hold PMI as of Q3 2026.

Citigroup held 1,709 shares of Picard Medical worth $7.18K as of Q3 2026.
Picard Medical was a new Citigroup position in Q3 2026.
Picard Medical made up ﹤0.01% of Citigroup's portfolio in Q3 2026, its #5279 holding.
Citigroup first reported a position in Picard Medical in Q4 2025 and has held it in 3 quarters since.
9 funds tracked by Wall St. Rank held Picard Medical as of Q3 2026.

Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.